Suvretta Capital Management's book
3 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| VeraDermics (NYS: MANE) | Drug Discovery | $596.3M | — | — | |
| connectRN | — | $256.0M | — | — | |
| Avalyn Pharma | — | $155.0M | — | — |
Free account
See the whole book
- ·Watchlist + alerts for Suvretta Capital Management's activity
Create free account
No card required